Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differentiation modifiers.

P A Marks, R A Rifkind

    Cancer
    |December 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Simple chemical compounds can induce transformed cells, like murine erythroleukemia cells (MELCs), to differentiate and stop proliferating. This offers a potential alternative cancer treatment by promoting terminal cell division.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical spectrum of hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency.

    Annals of internal medicine·2013
    Same author

    Excess alpha chain synthesis relative to beta chain synthesis in thalassaemia major and minor.

    Nature·2010
    Same author

    THE APPLICATION OF FERRITIN-CONJUGATED ANTIBODY TO ELECTRON MICROSCOPIC STUDIES OF INFLUENZA VIRUS IN INFECTED CELLS : I. THE CELLULAR SURFACE.

    The Journal of experimental medicine·2009
    Same author

    THE APPLICATION OF FERRITIN-CONJUGATED ANTIBODY TO ELECTRON MICROSCOPIC STUDIES OF INFLUENZA VIRUS IN INFECTED CELLS : II. THE INTERIOR OF THE CELL.

    The Journal of experimental medicine·2009
    Same author

    THE INTRACELLULAR DISTRIBUTION OF GAMMA GLOBULIN IN A MOUSE PLASMA CELL TUMOR (X5563) AS REVEALED BY FLUORESCENCE AND ELECTRON MICROSCOPY.

    The Journal of experimental medicine·2009
    Same author

    Histone deacetylase inhibitors: Potential in cancer therapy.

    Journal of cellular biochemistry·2009
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    Same journal

    Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

    Cancer·2026
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    See all related articles

    Area of Science:

    • Cell Biology
    • Cancer Research
    • Chemical Biology

    Background:

    • Transformed cell lines often exhibit uncontrolled proliferation and lack differentiation.
    • Cytotoxic agents are standard cancer treatments but can have significant side effects.
    • Inducing differentiation offers a potential alternative therapeutic strategy for neoplastic diseases.

    Purpose of the Study:

    • To summarize evidence on chemical inducers of cell differentiation.
    • To explore the potential of these inducers as an alternative to cytotoxic cancer therapies.
    • To highlight the need for further research into predicting inducer efficacy.

    Main Methods:

    • Review of studies investigating chemical induction of differentiation in transformed cell lines.
    • Analysis of the effects of inducers on cell proliferation and differentiation markers.

    Related Experiment Videos

  • Evaluation of the potential therapeutic implications of these findings.

    • Main Results:

    • Several simple chemical compounds can induce murine erythroleukemia cells (MELCs) and other transformed cells to differentiate.
    • Induced differentiation leads to loss of proliferative capacity and expression of differentiated characteristics.
    • These agents trigger specific events promoting differentiation and loss of oncogenic properties.

    Conclusions:

    • Chemical inducers of differentiation represent a promising alternative approach for treating certain cancers.
    • Further research is needed to identify which transformed cell lines are susceptible to these inducers.
    • Predicting efficacy is crucial for advancing these agents towards in vivo trials for neoplasms.